SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-097870
Filing Date
2022-09-06
Accepted
2022-09-06 16:30:39
Documents
13
Period of Report
2022-09-06
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2225124d1_8ka.htm   iXBRL 8-K/A 37966
2 EXHIBIT 99.3 tm2225124d1_ex99-3.htm EX-99.3 150003
  Complete submission text file 0001104659-22-097870.txt   376870

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA syn-20220906.xsd EX-101.SCH 3060
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220906_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220906_pre.xml EX-101.PRE 22614
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2225124d1_8ka_htm.xml XML 4688
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12584 | Film No.: 221228618
SIC: 2834 Pharmaceutical Preparations